Abnormalities in the pontine nuclei (PN) and inferior olive are hallmarks of human retinoic acid (RA) teratogenesis. This study shows that RA exposure of the mouse at a specific embryonic stage alters morphological structures that derive from the wall of the IVth ventricle to form components of the precerebellar system (the inferior olivary nucleus and the PN). The study employs both normal and a RAREhspLacZ transgenic RA reporter mouse. It is shown that abnormalities in the PN and inferior olive result from exposure at a critical period of embryonic day 9.5 and 10.5. The abnormalities in the PN are due to a failure in their usual neurophilic migration. The compact stream of cells that leads from the anterior rhombic lip to the ventral pons is instead scattered widely over the anterior medulla. Given that the RA exposure occurs after the resolution of rhombomere identity this suggests that teratogenic RA interferes with a regulatory event that overlays this original pattern. q
Introduction
Vitamin A was first identified as a teratogen nearly 50 years ago by Cohlan in experiments with rats (Cohlan, 1953) . In the decade that followed Kochhar demonstrated that retinoic acid (RA) was significantly more teratogenic than vitamin A (Kochhar, 1967) . The molecular mechanism by which RA initiated a biological effect was, however, not determined until the late 1980s when the RA receptors were identified as members of the steroid/thyroid hormone nuclear receptor family of transcriptional activators (Giguère et al., 1987; Petkovich et al., 1987) . RA has been found to be very effective for the treatment of a number of dermatological diseases, in particular chronic cystic acne (Peck et al., 1979) . Unfortunately, oral treatment with 0.5 to 2 mg/kg/d Accutane (13-cis RA) revealed that RA is also potently teratogenic for humans. The abnormalities in the CNS have been extensively described (Coberly et al., 1996) and the hindbrain is one area particularly sensitive. Malformations in this region include cerebellar hypoplasia as well as agenesis of the cerebellar vermis, abnormalities of the pontine nuclei (PN) and inferior olive and cystic dilation of the fourth ventricle. A similar set of hindbrain abnormalities has been described in the macaque monkey (Makori et al., 2001) .
The sensitivity of a region to RA often reflects the region's normal requirement for endogenous RA. The explanation for this is that when exogenous RA is present at an inappropriate time, place, or concentration, it interferes with those systems primed to respond to controlled RA levels. Areas of the CNS sensitive to RA teratogenicity, for example the eye (Shenefelt, 1972) , ear (Mallo, 1997) and spinal cord (Shenefelt, 1972) are also regions that require RA for normal development (Lohnes et al., 1994; Maden et al., 1996; Sockanathan and Jessell, 1998) . The hindbrain is another such area that requires endogenous RA as a developmental regulator. In the mouse RA was shown to alter the pattern of the rhombomeres through changes in the hox gene code, as reviewed by Gavalas and Krumlauf (2000) . Generally it is the posterior hindbrain that has the most acute requirement for RA and it has been suggested that a gradient of RA, highest at the posterior end, is necessary for the correct ordering of the rhombomeres (Dupe et al., 1999; Dupe and Lumsden, 2001; Gavalas and Krumlauf, 2000; Maden, 1999; Niederreither et al., 2000; Sakai et al., 2001) .
However, the effects of early RA exposure of the mouse embryo (Marshall et al., 1992) do not mimic the appearance of the human hindbrain exposed to RA. It is likely that the multiple abnormalities that result from early embryonic exposure result in premature embryonic death without the development of later brain structures. Evidence exists that later periods of hindbrain development require RA; in particular, the PN and inferior olive (manuscript in preparation). It would be expected that later exposure to RA would also disrupt these events and, indeed, these three brain regions are targets of RA teratogenesis in man (Lammer and Armstrong, 1992) . A common factor between these regions is that they all derive from the neuroepithelium of the dorsal hindbrain known as the rhombic lip (Wingate, 2001 ). This provides neurons for the PN and inferior olive and granule cell precursors for the cerebellum. If the rhombic lip precursors were overtly sensitive to RA teratogenicity then abnormalities would result in structures derived from these progenitors.
To follow the events of RA teratogenesis this report employs a 'RA reporter mouse' that provides a guide to regions of RA signaling through the localization of betagalactosidase expression driven by a RA response element. The regions of RA signaling labeled by beta-galactosidase are also those acutely sensitive to RA teratogenicity, i.e. the PN and inferior olive. The critical period for both the PN and inferior olive is between embryonic day 9.5 -10.5. We find that the abnormalities of the PN are, at least in part, due to a failure of the cells to follow the correct migration pathway. This may be a result of a disruption in a set of boundaries along the anterior/posterior axis of the embryonic hindbrain that the precerebellar neurons follow in their migration from the rhombic lip to the ventral pons.
Results

Beta-galactosidase staining in control animals
The regions of the brain most susceptible to RA teratogenesis are those areas that require RA for their normal development. To study the effects of teratogenic RA on these regions we employed a RA reporter mouse transgenic strain. These mice are transgenic for a RAREhsplacZ construct with three copies of the RA response element (RARE) from RAR beta upstream of the promoter from the mouse heat-inducible hsp68 gene driving the lacZ reporter gene. Endogenous RA activates this transgene resulting in the synthesis of beta-galactosidase and hence can be used to identify regions of RA signal transduction. As a transgenic model of RA signaling, a certain level of uncertainty exists in regard to the pattern of RAREhsplacZ expression because other regulators of nuclear receptor transcription may influence the precise expression pattern and transgene expression does not confirm that RA signaling occurs in a particular tissue. However, in the case of the PN and the inferior olive the induction of RAREhsplacZ by exogenous RA as seen in Fig. 1d , g and h, as compared to the uninduced embryo in Fig. 1a , suggests that RA induction significantly contributes to RAREhsplacZ expression in these nuclei.
In general, our observations on the RAREhsplacZ transgenic animals were similar to those of previous studies but attention was paid to specific areas of the hindbrain. At embryonic day 17.5 the spinal cord and the posterior medial edge of the tectum are strongly labeled (Fig. 1a -c ). In the hindbrain three regions are labeled-the cerebellum, the PN and the inferior olive. Labeling in the cerebellum is restricted to a set of parasagittal stripes in the vermis as well as the germinal trigone (GT) at the posterior lip of the cerebellum where progenitors of the granule cells are born. The PN are strongly labeled together with a tight stream of cells migrating from the anterior rhombic lip to the PN. This is the anterior precerebellar migratory stream (aPS, Fig. 1c ) that provides neurons for the PN (Altman and Bayer, 1997) . These patterns of RAREhsplacZ are the result of the combined effect of the expression of RA synthesizing enzymes in the meninges, RA catabolic enzymes in the hindbrain and the distribution of RA receptors and nuclear coactivators and corepressors (manuscript in preparation). This report uses the RAREhsplacZ as a marker for those regions in which RA signaling occurs. Tissues that require RA signaling for development are those regions most acutely sensitive to RA as a teratogen. The RAREhsplacZ positive regions in the hindbrain, i.e. the cerebellar vermis, the PN and the inferior olive are the hindbrain areas known to be susceptible to RA teratogenicity in man (Lammer and Armstrong, 1992) . Use of RAREhsplacZ provides a putative indicator of areas most likely to develop abnormally in the presence of teratogenic levels of RA.
The effects of RA injection on hindbrain RAREhspLacZ expression
RA is known to have profound effects on the brain during early stages of pattern formation (Krumlauf et al., 1993; Morriss-Kay et al., 1991) . The meticulous study of Shenefelt in hamsters (Shenefelt, 1972) showed that the abnormalities of the brain such as exencephaly occurred between the equivalent mouse ages (Dettlaff and Vassetzky, 1989 ) of embryonic day 7 -8.5 with a RA dose of 60 mg/kg. This agrees with the results of Kuno et al. in which murine exencephaly with 30 mg/kg RA peaked at embryonic day 8 (Kuno et al., 1999) . Zimmer and Zimmer (1992) reported that a 10 mg/kg dose of RA at embryonic day 7.5 was highly teratogenic whereas the same dose at embryonic day 8.5 resulted in only a low frequency of brain defects. However, brain abnormalities clearly occur with doses of RA at later embryonic periods. Shenefelt showed that the microcephalic abnormalities exhibited two peaks of RA sensitivity between equivalent mouse ages of embryonic days 8 -9 and then embryonic day 10.5 -11. Exposure of the rat embryo between embryonic days 11-13 (equivalent to embryonic days 10 -12 in the mouse) at 10 mg/kg RA resulted in a decrease in cerebellar weights and abnormalities in the inferior olive and area postrema (Holson et al., 1997a) . These abnormalities were associated with breathing and nursing problems in the newborn (Holson et al., 1997a) . Lower doses of RA (2.5 mg/kg) resulted in behavioral abnormalities in the adult (Holson et al., 1997b) .
In our experiments, mice were injected with 30 mg/kg RA intraperitoneally at four different periods. Two injections were given on two consecutive days. These injections covered the range between embryonic days 8.1 -14.5. The mice were sacrificed at embryonic day 17.5 because animals could not survive after birth due to brainstem defects, and the mid-and hindbrain were developed for RAREhsplacZ activity.
The most dramatic effects on RAREhspLacZ were evident in the ventral hindbrain with RA injections at embryonic days 9.5 and 10.5 (Fig. 1e ). RAREhsplacZ was induced outside its normal distribution pattern but staining in both the PN and inferior olive was absent as compared to the control (Fig. 1a) . Complete or severe reduction in staining in the PN and inferior olive was evident in five out of five treated pregnant mothers. Injections outside of this period, either earlier at embryonic days 8.1 and 9.1 (Fig. 1d) , or later at embryonic day 10.5 and 11.5, 12.5 and 13.5 or 13.5 and 14.5 (Fig. 1f , g and h) had a much lesser effect. Single day injections on either embryonic day 9.5 or 10.5 caused similar abnormalities but to a lesser degree, suggesting the duration of exposure to RA is critical (results not shown).
The disappearance of the PN and inferior olive after RA treatment at embryonic day 9.5 and 10.5 is confirmed in nissl stained sections of pons and medulla at embryonic day 18 (Fig. 2) . RA does not simply repress RAREhsplacZ transgene expression in these nuclei but results in loss of the cells of the PN ( Fig. 2b and d ) and the inferior olive ( Fig. 2h and j). At higher magnification it is evident that all components of both nuclei are missing ( Fig. 2f and l) . Although shows the ventral hindbrain of a control embryo (a) in which the inferior olive (10) and PN are both labeled; (b) shows the dorsal hindbrain, with meninges attached, with labeling of the spinal cord (SpC) as well as the germinal trigone (GT) of the cerebellum and a set of parasagittal stripes in the cerebellar vermis (Vrm); (c) shows a lateral view of the hindbrain with meninges attached with the beta-galactosidase labeled migrating pontine neurons in the anterior precerebellar stream (aPS). The critical period for the loss of beta-galactosidase expression in the inferior olive and PN following RA exposure is shown in (d-h). Pregnant mice were injected with RA at either embryonic days (d) 8.1 and 9.1, (e) 9.5 and 10.5, (f) 10.5 and 11.5, (g) 12.5 and 13.5 or (h) 13.5 and 14.5 and sacrificed at embryonic day 17.5. A complete absence of PN and inferior olive (IO) beta-galactosidase staining resulted from RA exposure at embryonic days 9.5 and 10.5 (e). 1 mm scale bar for (a -c) is given in (a). 1 mm scale bar for (d-h) is given in (d). Med, Medulla; Cb, Cerebellum; SC, Superior Colliculus.
these nuclei are lost it is evident from these figures that there is a general increase in girth of the hindbrain with RA treatment in both the pons and medulla.
RA effects on migrating pontine neuron progenitors
To understand more about the process by which RA exposure obstructs PN development, RA teratogenesis following embryonic days 9.5 and 10.5 exposure was studied at an earlier period, embryonic day 15.5. Fig. 3a shows streaming of the neurons, born in the anterior rhombic lip, which merge together to bundle, in neurophilic fashion, to form the narrow anterior precerebellar stream that leads to the PN (Fig. 3c, aPS) . After exposure to RA however this tight stream has vanished ( Fig. 3b and d) and, while RAREhspLacZ positive neurons can be seen streaming down from the rhombic lip, they no longer accumulate into a discrete bundle but instead are spread across the anterior hindbrain, and are noticeably absent from the posterior medulla. This spread of migrating neurons occurred in four out of four pregnant mice exposed to RA.
The transcription factor pax-6 is expressed in the same pool of migrating pontine neurons (Engelkamp et al., 1999; Yee et al., 1999) as RAREhsplacZ. The loss of the pax-6 positive neurons and their aberrant migration at embryonic day 15, after RA treatment on embryonic day 9.5 and 10.5, is confirmed in sections immunohistochemically labeled for pax-6 (Fig. 4) . At embryonic day 15, in the control animals, the stream of migrating pontine neurons is clearly labeled; however, in RA treated mice this stream appears scattered ( Fig. 4c and d ). Higher magnification shows that the solid stream of cells seen in the aPS is broken up into a wide band where individual cells can be distinguished ( Fig. 4e and f) . By embryonic day 18, most of the pontine migrating cells have disappeared in the controls (Fig. 4i) , but some are still expressed in RA treated mice (Fig. 4j) . These late migrating cells are not evident in the RAREhsplacZ transgenic mouse (Fig. 1) probably due to the greater sensitivity of the immunohistochemical technique. Clearly, however, in the RA treated mouse the PN have failed to form (Fig. 3f) .
Changes in anterior rhombomeres
RA exposure at embryonic day 9.5 and 10.5 interferes with the migratory route of the pontine neurons along the anterior precerebellar migratory pathway and may also prevent the normal migration of neurons that generate other hindbrain nuclei. The changes in RA regulated gene Fig. 4 . Effect of embryonic day 9.5 and 10.5 RA exposure on E15 hindbrain pax-6 expression. In sections of E15 (a -f) or E18 (g-j) hindbrain treated with RA at embryonic day 9.5 and 10.5 and immunostained for pax-6 protein expression shows a similar loss of PN and disruption of the precerebellar stream. Pax-6 immunohistochemistry was performed on 100 mm vibratome sections through either medial (a, b, g, h) or lateral (c -f, i, j) hindbrain either untreated (a, c, e, g, i) or RA treated (b, d, f, h, j). The pax-6 positive cells in the PN of embryonic day 15 (a) and 18 (g) controls are clearly evident in medial sections. These same cells are reduced in the RA treated embryonic day 15 (b) and 18 hindbrains (h). A control lateral section at embryonic day 15 (c) shows the pax-6 cells in the anterior precerebellar stream (aPS) as they migrate to the PN but migration is almost complete by embryonic day 18 (i). This migratory pathway is noticeably scattered following RA treatment (d) and this is more marked at higher magnification when the dense migratory stream in the control (e) is spread over a wide band after RA treatment (f). Migrating cells are still evident at embryonic day 18 in the RA treated embryo (j) but are absent in the control (i). Scale bar, 1 mm. SpC, Spinal Cord; Med, Medulla; Cb, Cerebellum; v4, fourth ventricle; ChPI, choroid plexus. Fig. 5 . Effect of embryonic day 9.5 and 10.5 RA exposure on E11.5 hindbrain RAREhspLacZ, Hoxa-2, Pax-6 and CRABPI expression. A comparison is made between untreated (a, c, e, g, i) and RA exposed (b, d, f, h, j) flat-mounted hindbrain either developed for RAREhspLacZ (a, b) or hybridized with labeled riboprobes for Hoxa-2 (c, d), Pax-6 (e, f) or CRABPI in dorsal (g, h) or ventral view (i, j). In the untreated dorsal hindbrain (a) RAREhspLacZ is present in a ventral stripe in the posterior hindbrain up to the rhombomere 2/3 boundary. After RA treatment (b) RAREhspLacZ is induced throughout the hindbrain but is much stronger in the anterior medulla. Hoxa-2 shows strongest expression in rhombomeres 3 and 4 (c) and this is lost following RA treatment (d). Pax-6 lies along the ventral boundaries of the anterior rhombomeres and is present as a continuous ventral stripe along the posterior hindbrain (e). Following RA exposure anterior Pax-6 expression is markedly decreased anteriorly whereas its posterior expression is maintained (f). CRABPI in dorsal (g) or ventral (i) aspect is expressed predominantly along a dorsal stripe up to rhombomere 4, is negative in rhombomere 3 and 2 and expression continues in rhombomere 1. CRABPI levels in the dorsal stripe are extended after RA treatment into rhombomeres 2 and 3 as seen from dorsal (h) or ventral (j) view. Scale bar, 1 mm. expression that initiate these events must occur immediately after the exposure to RA. The expression of RAREhsplacZ at embryonic day 11.5 was compared in control (Fig. 5a ) and embryonic day 9.5 and 10.5 RA treated embryos (Fig. 5b) . RAREhsplacZ in the future medulla is expressed along two stripes in the ventral midline either side of the medline up to the rhombomere 2/3 boundary. Further dorsal to this stripe is a second line of weak expression with a similar anterior boundary. Exposure to RA results in an anterior/posterior reversal in the intensity of RAREhsplacZ. Although the entire hindbrain is labeled it is the anterior hindbrain that shows significantly stronger labeling. Within this region of high RA signaling there is also a change in expression of anterior rhombomere gene expression, two of which, Hoxa-2 and Pax-6, are reduced. The anterior most of the Hox genes, Hoxa-2, is strongly present in rhombomeres 3 and 4 (Davenne et al., 1999) (Fig. 5c ) and this expression is much repressed after RA treatment (Fig. 5d) . Similarly, Pax-6 (Fig. 4e) , which is present at the ventral boundaries of anterior rhombomeres (Heyman et al., 1995) , is no longer detectable in these rhombomere divisors even though expression of Pax-6 is maintained in the posterior hindbrain (Fig. 5f ). It is of interest that Pax-6 is expressed along the posterior medulla along a ventral stripe overlapping with RAREhspLacZ expression (Fig. 5a and e) . The anterior region of Pax-6 loss ( Fig. 5f ) after RA treatment is in a similar anterior region as the area of RAREhspLacZ overexpression (Fig. 5b) .
The cellular RA binding protein I (CRABPI), which is RA inducible (Wei et al., 1989) , behaves differently to Hoxa-2 and Pax-6 and is upregulated. This gene is normally expressed along the hindbrain up to the rhombomere 3/4 boundary, is absent from rhombomere 4, and then is more weakly expressed in rhombomere 2 (Maden et al., 1992) . Fig. 6g and i show intense expression of CRABPI along the dorsal edge of the hindbrain, up to the rhombomere 3/4 boundary. This labeling is absent from rhombomere 3 and neither is it detectable in rhombomere 2; however, a dorsal stripe is evident in rhombomere 1, which is CRABPI negative at earlier stages (Leonard et al., 1995) . RA exposure at embryonic day 9.5 and 10.5 results in advancement of expression ( Fig. 5h and j) , an event which also occurs following RA exposure as early as embryonic day 7.75 (Leonard et al., 1995) . In the case of embryonic day 9.5 and 10.5 exposure, however, CRABPI expression is extended to reach the posterior boundary of the CRABPI stripe in rhombomere 1 (i.e. the rhombomere 1/2 boundary, Fig. 5h and j) . The reduction in expression in pax-6 and Hoxa-2, as well as the changes in CRABP-1 pattern with RA exposure, were evident in three out of three litters assayed, testing 2 -3 embryos from each litter per probe. The transcription factor En-2 was also examined as a gene present at the mid/ hindbrain boundary and its pattern was unaffected (results not shown).
Discussion
The teratogenic effects of RA in the developing hindbrain have been described in human, monkey and rat (Coberty et at., 1996; Hendrickx et al., 1998; Holson et al., 1999 Holson et al., , 1997a Lammer and Armstrong, 1992; Makori et al., 2001) ; frequent targets being the cerebellar vermis, PN and inferior olive. The RAREhsplacZ transgenic mouse was used in this study to help identify regions of RA signaling in the developing hindbrain. It was notable that the cerebellar vermis, PN and inferior olive were all labeled providing an initial indicator that these structures were possibly responsive to RA. This might account for the sensitivity of these regions to teratogenic RA. Injections of RA early during development, at embryonic day 8.5, induce RAREhsplacZ throughout the embryo 2 days after exposure (Rossant et al., 1991) . As evident in Fig. 1 , RA injections at embryonic day 8.1 and 9.1 do not induce RAREhsplacZ through the entire embryo when examined at embryonic day 17.5, presumably due to growth of the embryo in the intervening period. Injections at embryonic day 15 and 16, however, label an even more restricted area, essentially only intensifying expression in regions that express RAREhsplacZ without injection of exogenous RA. RAREhsplacZ expression in the unexposed embryo labels the regions of normal RA signaling, suggesting that development of the inferior olive and PN is possibly regulated by RA. A source of RA would be from the RA synthesizing enzyme RALDH2 present in the surrounding meninges (Niederreither et al., 1997) . The absence of RAREhsplacZ expression outside of these regions, even after RA injection, implies the existence of (unknown) repressors of RA receptor activation. However, for the purpose of this study, RAREhsplacZ expression is used as a marker for the PN and inferior olive. RA can prevent the development of both structures and, at least for the PN, its application at embryonic day 9.5/10.5 is before birth of these neurons between embryonic day 12-16 (Taber-Pierce, 1966) . If RA exposure still allows pontine neuron progenitors to be born, what event, essential for the formation of the PN, is blocked by RA?
The investigation had initially focused on a later period of hindbrain development (embryonic day 17.5), at which point RAREhsplacZ expression in the PN and inferior olive was lost. At an earlier period (embryonic day 15.5) however it was evident that, although pontine neurons were generated and able to migrate around the medulla to the midline (Fig. 3) , they had lost their ability to track along the anterior precerebellar migratory route, and were distributed throughout the anterior medulla. The pontine neurons migrate by a process of neurophilic migration, in which the cells bundle together forming the thick fascicles that form the anterior precerebellar migratory route (Alcantara et al., 2000; Yee et al., 1999) . It is this thick strand that is lost following RA treatment. Smaller fascicles are still formed but they are not restricted to the bundle that constitutes the normal migratory stream.
What is the mechanism by which RA can interfere so profoundly with these migratory routes? Exposure of the hindbrain between embryonic day 7.5 and 8.0 resets the order of rhombomeres essentially posteriorizing the mouse hindbrain, transforming anterior rhombomeres into segments of more posterior identity (Marshall et al., 1992) . Such a shift in regional identity can switch, for instance, the migration pattern of anterior neural crest into a more posterior pathway (Lee et al., 1995) . A change in hox gene patterning can misdirect axons pathways, such as the hox-2 null mutant where the trigeminal motor neurons change their exit point (Gavalas et al., 1997) to that of rhombomere 4, the exit point of the facial nerve motor neurons. RA can similarly respecify the exit point of hindbrain motor neurons axons (Kessel, 1993) .
RA directed changes in rhombomere identity could thus alter cell migration. However, the changes in the pattern of the anterior precerebellar migratory route is not a switch in pathway direction but a loss in the cells ability to follow a normally preset path to the ventral pons. Further, exposure of the embryo at a time that would posteriorize the rhombomeres, i.e. embryonic day 8.5 and 9.5, does not significantly alter the development of the PN, although the morphology of the hindbrain is clearly altered. Exposure of the hindbrain at embryonic day 9.5 and 10.5 is subsequent to the period when rhombmere identity is determined (Tuckett et al., 1985) and, for instance, anterior induction of the hox-2 genes by RA does not occur after embryonic day 8 (Conlon and Rossant, 1992) . Hence RA must presumably act on patterns that come after this event. Gale et al. showed that late effects of RA on the chick hindbrain could change the characteristic of a rhombomere in respect to gene expression but did not delete or respecify the segment. This might include the final establishment of rhombomere boundaries. The anterior precerebellar migratory route lies along a position similar to that of the rhombomere 1/2 boundary. It has been suggested previously that the rhombomere boundaries (and the specialized glial cells and extracellular matrix that reside there) may be important in axon guidance and cell migration (Heyman et al., 1995) . If RA altered such boundaries this might result in the loss of the framework on which the anterior precerebellar migratory pathway is set. For instance, a shift in the anterior/posterior boundaries resulting from RA exposure is suggested by the anterior extension of CRABPI into the region of rhombomere 2 and 3 as well as the reduction of Hoxa-2 and Pax-6 expression in these anterior rhombomeres. It is also intriguing that the RAREhsplacZ reporter gene in the anterior hindbrain exhibits a greater sensitivity to RA exposure than regions anterior or posterior to this segment (Fig. 4b) . The scattered migratory path of the pontine neurons remains restricted to a similar anterior segment, suggesting that a boundary defining the migratory path may still exist, but it has been expanded to include this entire anterior segment. The loss of boundary definition within these anterior segments is suggested by the loss of Pax-6 at the rhombomere boundaries in this anterior zone (Fig. 5f ). The ventral posterior medulla stripe of Pax-6 overlaps with RAREhsplacZ expression at embryonic day 11.5 ( Fig. 5a and e) whereas anterior Pax-6, which follows the rhombomere boundaries, is in the region of low RAREhsplacZ expression. Anterior induction of RAREhsplacZ by RA overlaps with the area of pax-6 repression suggesting that it is the induction of RA signaling that down regulates pax-6 rhombomere boundary localization. Pax-6 may play a role in the differentiation of radial glia (Gotz et al., 1998) and it has been suggested that pax-6 may maintain the identity of the neuroepithelial, vimentin positive, cells at the rhombomere boundary (Heyman et al., 1995) . Loss of Pax-6 may disrupt these boundaries.
It can be concluded that abnormalities in the developing PN resulting from RA exposure at embryonic day 9.5 and 10.5 result in part from a dislocation of pontine neuron migration along the anterior/posterior axis, whereas they are still able to successfully traverse from the dorsal neuroepithelium to the ventral medulla. This is not to say that an altered migratory path is the only mechanism that reduces the number of pontine neurons. RA is an inducer of neural differentiation of many neural stem cells and cell lines (Andrews et al., 1990; Bain et al., 1995; McBumey, 1993; Takahashi et al., 1999) and premature differentiation of these cells may reduce the total number of cells born. Such changes will be the subject of future studies.
Experimental procedures
Animals
The mice used in these studies were obtained from an in-house RAREhsplacZ colony originally obtained from Rossant et al. (1991) . C57B16 were purchased from SLC (Japan). Embryos were staged following Theiler's criteria (Theiler, 1972) where the day of conception is defined as embryonic day 0. RA was given by intraperitoneal injection at a dose of 30 mg/kg. The pregnant animals were euthanized by cervical dislocation under isofluorane anesthesia and the embryos were removed and decapitated with or without perfusion by fixative through the heart. Embryonic brains were quickly dissected in ice-cold RPMI tissue culture medium with 10% FCS. For in situ hybridization, tissues were immersed into 4% paraformaldehyde in 0.1 M phosphate buffer (pH7.4) and fixed at room temperature for 2 h. Following fixation the embryo heads were transferred to 30% sucrose in phosphate buffer until they sank and were stored at 2 80 8C until use. To develop for beta-galactosidase the embryos were fixed for 30 min in 0.2% glutaraldehyde and assayed as previously described (McCaffery et al., 1999) .
In situ hybridization
Netrin and DCC probes were kindly donated by Dr. M. Tessier-Lavigne and Pax-6 probes were given by Dr T. Glaser. CRABPI probes were derived by PCR amplification of cDNA from embryonic day 13 heads using the specific primers caa cga tga gct aat cct gac a and gca gcc aac cag ttt aat ga derived from the available CRABPI sequence (Vaessen et al., 1989) . The resulting fragment, spanning nucleotides 441-743 were subcloned into pCRll-TOPO (Invitrogen). The whole mount in situ hybridization technique was as previously described (McCaffery et al., 1999) .
Immunocytochemistry
Pax 6 antibodies were from Chemicon and used at 1:1000 dilution in PBS with 1%NGS. Brains from C57B16 mice were sliced by vibratome in 100 mm thicknesses and incubated with primary antibody at 4 8C overnight. Sections were washed with phosphate buffered saline (PBS)-1%NGS for 3 £ 10 min, and reacted with Vector stain kit (Rabbit IgG) according to manufacturer's instruction.
